Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Naomi Kobayashi-Watanabe"'
Autor:
Futoshi Kawaura, Takuya Kishi, Tadashi Yamamoto, Shiki Nakayama, Taku Goto, Reimi Tsurusawa, Toshio Katagiri, Kohei Yamanouchi, Ayako Matsuo, Naomi Kobayashi-Watanabe, Tomohiro Imamura, Yoshitaka Hirooka, Kuniyasu Takagi, Tsukuru Umemura, Kazuma Fujimoto, Shinichiro Hayashi, Ayako Takamori
Publikováno v:
Drug Discoveries & Therapeutics. 17:60-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d25b3ccb0f7cd61d1cceb0fd7ab99ef3
https://doi.org/10.5582/ddt.2022.01111
https://doi.org/10.5582/ddt.2022.01111
Autor:
Kuniaki Takagi, Shinnichiro Hayashi, Ayako Matsuo, Zennzou Nagasawa, Yasunari Iwanaga, Naomi Kobayashi-Watanabe, Futoshi Kawaura, Ayako Takamori, Motohisa Kuwahara, Hitomi Ono, Kazuma Fujimoto
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
The present study aimed to reveal; i) risk for prolonged hospitalization and mortality in aged community acquired pneumonia patients, and ii) whether swallowing ability was related to re-hospitalization. The present retrospective study included 92 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c69beb54c1750d23732e4f6540d0b286
https://doi.org/10.3164/jcbn.20-85
https://doi.org/10.3164/jcbn.20-85
Autor:
Tatsuro Watanabe, Naoko Sueoka-Aragane, Chiho Nakashima, Eisaburo Sueoka, Tomonori Abe, Akemi Sato, Naomi Kobayashi-Watanabe, Shinya Kimura
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 110
Objectives Discoidin domain receptor (DDR) 2 mutations have recently been reported to be candidate targets of molecular therapy in lung squamous cell carcinoma (SQCC). However, the status of DDR2 expression and mutations, as well as their precise rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1943d8cb1e46257a5d87bfd4564fbd5f
https://pubmed.ncbi.nlm.nih.gov/28676216
https://pubmed.ncbi.nlm.nih.gov/28676216
Autor:
Naomi Kobayashi-Watanabe
Publikováno v:
Cancer Research. 76:407-407
The treatment strategy for lung cancer has been rapidly progressed, especially in molecular targeted therapy. However, most treatments are established for adenocarcinoma of lung, but not squamous cell carcinoma (SQCC). SQCC occupies approximately 30%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c556da6f7be90c6ca376d8c907546a47
https://doi.org/10.1158/1538-7445.am2016-407
https://doi.org/10.1158/1538-7445.am2016-407